These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6093663)

  • 1. NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.
    Decker JL; Malone DG; Haraoui B; Wahl SM; Schrieber L; Klippel JH; Steinberg AD; Wilder RL
    Ann Intern Med; 1984 Dec; 101(6):810-24. PubMed ID: 6093663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukapheresis and pathogenetic mechanisms in rheumatoid arthritis.
    Wilder RL; Malone DG; Yarboro CH; Berkebile C; Haraoui B; Allen JB; Wahl SM
    J Clin Apher; 1984; 2(1):112-8. PubMed ID: 6336086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
    Mariani L; Baratelli M
    Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of antirheumatic drugs.
    Parnham MJ
    Agents Actions Suppl; 1984; 14():153-69. PubMed ID: 6382972
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chlorbutin, azathioprine, d-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis patients. III. A comparative analysis of their effect on the morphological manifestations of synovitis based on puncture biopsy data].
    Shekhter AB; Krel' AA; Chichasova NV; Rashchupkina ZP
    Ter Arkh; 1984; 56(2):121-31. PubMed ID: 6710393
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis.
    Klimiuk PA; Goronzy JJ; Weyand CM
    J Immunol; 1999 Apr; 162(7):4293-9. PubMed ID: 10201961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in disease-modifying antirheumatic drugs.
    Hunneyball IM
    Prog Drug Res; 1980; 24():101-216. PubMed ID: 7005959
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.
    Malone DG; Wahl SM; Tsokos M; Cattell H; Decker JL; Wilder RL
    J Clin Invest; 1984 Oct; 74(4):1173-85. PubMed ID: 6384266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of rheumatoid arthritis.
    Dugowson CE; Gilliland BC
    Dis Mon; 1986 Jan; 32(1):1-74. PubMed ID: 3512214
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of treatment on circulating immune complexes in rheumatoid arthritis (author's transl)].
    Rosenthal M; Graf U; Müller W
    Dtsch Med Wochenschr; 1977 Mar; 102(12):415-8. PubMed ID: 844411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some aspects of slow-acting drugs in rheumatoid arthritis.
    Ansell BM
    Agents Actions Suppl; 1979; (5):111-9. PubMed ID: 294130
    [No Abstract]   [Full Text] [Related]  

  • 13. [The basic therapy of rheumatoid arthritis].
    Sigidin IaA
    Ter Arkh; 1988; 60(4):148-54. PubMed ID: 2899360
    [No Abstract]   [Full Text] [Related]  

  • 14. [The drug spectrum in rheumatoid arthritis therapy].
    Fellinger K
    Acta Med Austriaca; 1975; 2(4):105-10. PubMed ID: 1224926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
    Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
    Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigenic markers of immunocompetent cells in rheumatoid synovial membrane].
    Faure G; Bene MC; Bach MA; Bach JF; Duheille J; Gaucher A
    Rev Rhum Mal Osteoartic; 1983 Jun; 50(7):515-20. PubMed ID: 6225180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.
    Kokkola R; Sundberg E; Ulfgren AK; Palmblad K; Li J; Wang H; Ulloa L; Yang H; Yan XJ; Furie R; Chiorazzi N; Tracey KJ; Andersson U; Harris HE
    Arthritis Rheum; 2002 Oct; 46(10):2598-603. PubMed ID: 12384917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission-inducing therapy in rheumatoid arthritis.
    Lipsky PE
    Am J Med; 1983 Oct; 75(4B):40-9. PubMed ID: 6356907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do drugs change the course of rheumatoid arthritis?
    Wright V; Amos R
    Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.